P
Paul B. Fisher
Researcher at Virginia Commonwealth University
Publications - 486
Citations - 35304
Paul B. Fisher is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Cancer & Cancer cell. The author has an hindex of 80, co-authored 449 publications receiving 31149 citations. Previous affiliations of Paul B. Fisher include Discovery Institute & Columbia University Medical Center.
Papers
More filters
Effect on Transformation ofMutations intheEarlyRegion lb-Encoded 21-and55-Kilodalton Proteins ofAdenovirus 5
TL;DR: Uponinfection ofcloned ratembryofibroblast cells withviruses containing mutations affecting the55-kdprotein, theformation frequency decreased asthesize of the predicted truncated polypeptide decreased and theefectiveness intransformation observed after infection withvirions was not as dramatic.
Journal Article
Wild-type Adenovirus Type 5 Transforming Genes Function as Transdominant Suppressors of Oncogenesis in Mutant Adenovirus Type 5 Transformed Rat Embryo Fibroblast Cells
Zao-Zhong Su,Jorge A. Leon,Hongping Jiang,Vincent N. Austin,Stephen G. Zimmer,Paul B. Fisher +5 more
TL;DR: Results indicate that both the wt Ad5 E1A and wt adenovirus type 5 E1B genes can function as dominant suppressors of the oncogenic process when coexpressed in H5hr1-transformed CREF cells.
Journal ArticleDOI
Posttranscriptional Inhibition of Protein Tyrosine Phosphatase Nonreceptor Type 23 by Staphylococcal Nuclease and Tudor Domain Containing 1: Implications for Hepatocellular Carcinoma
Nidhi Jariwala,Rachel G. Mendoza,Dawn Garcia,Zhao Lai,Mark A. Subler,Jolene J. Windle,Nitai D. Mukhopadhyay,Paul B. Fisher,Yi Chen,Devanand Sarkar +9 more
TL;DR: RNA interactome of SND1 is identified, and the findings identify PTPN23 as a unique tumor suppressor for HCC, suggesting that it might function as a homeostatic regulator of multiple kinases, restraining their activation.
Journal ArticleDOI
Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
Maaged A. Akiel,Devaraja Rajasekaran,Rachel Gredler,Ayesha Siddiq,Jyoti Srivastava,Chadia L. Robertson,Nidhi Jariwala,Paul B. Fisher,Devanand Sarkar +8 more
TL;DR: A comprehensive discussion of the role of IGFBP7 in HCC and the potential use of IGF BP7 as a novel biomarker for drug resistance and as an effective therapeutic strategy is provided.